Citation: A. Kopp-schneider et Wk. Lutz, J-shaped dose-response relationship for tumor induction by caffeic acid inthe rat forestomach, modeled by non-monotonic dose response for DNA damageand cell proliferation, HUM ECOL R, 7(4), 2001, pp. 921-931
Citation: A. Kopp-schneider, Using a stochastic model to analyze the sequence of phenotypic changes in rat liver focal lesions, MATH COMP M, 33(12-13), 2001, pp. 1289-1295
Authors:
Bartoszynski, R
Edler, L
Hanin, L
Kopp-Schneider, A
Pavlova, L
Tsodikov, A
Zorin, A
Yakovlev, AY
Citation: R. Bartoszynski et al., Modeling cancer detection: tumor size as a source of information on unobservable stages of carcinogenesis, MATH BIOSCI, 171(2), 2001, pp. 113-142
Authors:
Stassar, MJJG
Devitt, G
Brosius, M
Rinnab, L
Prang, J
Schradin, T
Simon, J
Petersen, S
Kopp-Schneider, A
Zoller, M
Citation: Mjjg. Stassar et al., Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization, BR J CANC, 85(9), 2001, pp. 1372-1382
Authors:
Portier, CJ
Sherman, CD
Kopp-Schneider, A
Citation: Cj. Portier et al., Multistage, stochastic models of the cancer process: A general theory for calculating tumor incidence, STOCH ENV R, 14(3), 2000, pp. 173-179
Authors:
Queisser, W
Hartung, G
Kopp-Schneider, A
Diezler, P
Hagmuller, E
Baur, A
Weniger, J
Wojatschek, C
Janssen, N
Hossfeld, D
Lindemann, H
Schnabel, T
Edler, L
Citation: W. Queisser et al., Adjuvant radio-chemotherapy with 5-fluorouracil and leucovorin in stage IIand III rectal cancer: 12 months vs. 6 months of therapy - A study of the Association for Medical Oncology of the German Cancer Society, ONKOLOGIE, 23(4), 2000, pp. 334-339
Authors:
Radaeva, S
Li, YH
Hacker, HJ
Burger, V
Kopp-Schneider, A
Bannasch, P
Citation: S. Radaeva et al., Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks, J HEPATOL, 33(4), 2000, pp. 580-600
Authors:
Rojas, M
Cascorbi, I
Alexandrov, K
Kriek, E
Auburtin, G
Mayer, L
Kopp-Schneider, A
Roots, I
Bartsch, H
Citation: M. Rojas et al., Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism, CARCINOGENE, 21(1), 2000, pp. 35-41
Citation: I. Geisler et A. Kopp-schneider, A model for hepatocarcinogenesis with clonal expansion of three successivephenotypes of preneoplastic cells, MATH BIOSCI, 168(2), 2000, pp. 167-185
Citation: Wk. Lutz et A. Kopp-schneider, Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay, TOXICOL SCI, 49(1), 1999, pp. 110-115
Authors:
Koesters, R
Ridder, R
Kopp-Schneider, A
Betts, D
Adams, V
Niggli, F
Briner, J
Doeberitz, MV
Citation: R. Koesters et al., Mutational activation of the beta-catenin proto-oncogene is a common eventin the development of Wilms' tumors, CANCER RES, 59(16), 1999, pp. 3880-3882
Authors:
Strobel, P
Klimek, F
Zerban, H
Kopp-Schneider, A
Bannasch, P
Citation: P. Strobel et al., Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine, CARCINOGENE, 19(12), 1998, pp. 2069-2080